IBDEI23K ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,35193,1,4,0)
 ;;=4^E11.319
 ;;^UTILITY(U,$J,358.3,35193,2)
 ;;=^5002633
 ;;^UTILITY(U,$J,358.3,35194,0)
 ;;=E11.40^^163^1793^10
 ;;^UTILITY(U,$J,358.3,35194,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35194,1,3,0)
 ;;=3^DM Type 2 w/ Diabetic Neuropathy,Unspec
 ;;^UTILITY(U,$J,358.3,35194,1,4,0)
 ;;=4^E11.40
 ;;^UTILITY(U,$J,358.3,35194,2)
 ;;=^5002644
 ;;^UTILITY(U,$J,358.3,35195,0)
 ;;=E11.41^^163^1793^9
 ;;^UTILITY(U,$J,358.3,35195,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35195,1,3,0)
 ;;=3^DM Type 2 w/ Diabetic Mononeuropathy
 ;;^UTILITY(U,$J,358.3,35195,1,4,0)
 ;;=4^E11.41
 ;;^UTILITY(U,$J,358.3,35195,2)
 ;;=^5002645
 ;;^UTILITY(U,$J,358.3,35196,0)
 ;;=E11.42^^163^1793^13
 ;;^UTILITY(U,$J,358.3,35196,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35196,1,3,0)
 ;;=3^DM Type 2 w/ Diabetic Polyneuropathy
 ;;^UTILITY(U,$J,358.3,35196,1,4,0)
 ;;=4^E11.42
 ;;^UTILITY(U,$J,358.3,35196,2)
 ;;=^5002646
 ;;^UTILITY(U,$J,358.3,35197,0)
 ;;=E11.43^^163^1793^7
 ;;^UTILITY(U,$J,358.3,35197,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35197,1,3,0)
 ;;=3^DM Type 2 w/ Diabetic Autonomic Polyneuropathy
 ;;^UTILITY(U,$J,358.3,35197,1,4,0)
 ;;=4^E11.43
 ;;^UTILITY(U,$J,358.3,35197,2)
 ;;=^5002647
 ;;^UTILITY(U,$J,358.3,35198,0)
 ;;=E11.51^^163^1793^11
 ;;^UTILITY(U,$J,358.3,35198,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35198,1,3,0)
 ;;=3^DM Type 2 w/ Diabetic Peripheral Angiopathy w/o Gangrene
 ;;^UTILITY(U,$J,358.3,35198,1,4,0)
 ;;=4^E11.51
 ;;^UTILITY(U,$J,358.3,35198,2)
 ;;=^5002650
 ;;^UTILITY(U,$J,358.3,35199,0)
 ;;=E11.52^^163^1793^12
 ;;^UTILITY(U,$J,358.3,35199,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35199,1,3,0)
 ;;=3^DM Type 2 w/ Diabetic Peripheral Angiopathy w/ Gangrene
 ;;^UTILITY(U,$J,358.3,35199,1,4,0)
 ;;=4^E11.52
 ;;^UTILITY(U,$J,358.3,35199,2)
 ;;=^5002651
 ;;^UTILITY(U,$J,358.3,35200,0)
 ;;=E11.621^^163^1793^14
 ;;^UTILITY(U,$J,358.3,35200,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35200,1,3,0)
 ;;=3^DM Type 2 w/ Foot Ulcer
 ;;^UTILITY(U,$J,358.3,35200,1,4,0)
 ;;=4^E11.621
 ;;^UTILITY(U,$J,358.3,35200,2)
 ;;=^5002656
 ;;^UTILITY(U,$J,358.3,35201,0)
 ;;=E11.641^^163^1793^16
 ;;^UTILITY(U,$J,358.3,35201,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35201,1,3,0)
 ;;=3^DM Type 2 w/ Hypoglycemia w/ Coma
 ;;^UTILITY(U,$J,358.3,35201,1,4,0)
 ;;=4^E11.641
 ;;^UTILITY(U,$J,358.3,35201,2)
 ;;=^5002661
 ;;^UTILITY(U,$J,358.3,35202,0)
 ;;=E11.649^^163^1793^17
 ;;^UTILITY(U,$J,358.3,35202,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35202,1,3,0)
 ;;=3^DM Type 2 w/ Hypoglycemia w/o Coma
 ;;^UTILITY(U,$J,358.3,35202,1,4,0)
 ;;=4^E11.649
 ;;^UTILITY(U,$J,358.3,35202,2)
 ;;=^5002662
 ;;^UTILITY(U,$J,358.3,35203,0)
 ;;=H40.11X0^^163^1794^8
 ;;^UTILITY(U,$J,358.3,35203,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35203,1,3,0)
 ;;=3^Glaucoma,Primary Open-Angle,Unspec Stage
 ;;^UTILITY(U,$J,358.3,35203,1,4,0)
 ;;=4^H40.11X0
 ;;^UTILITY(U,$J,358.3,35203,2)
 ;;=^5005753
 ;;^UTILITY(U,$J,358.3,35204,0)
 ;;=H40.11X1^^163^1794^5
 ;;^UTILITY(U,$J,358.3,35204,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35204,1,3,0)
 ;;=3^Glaucoma,Primary Open-Angle,Mild Stage
 ;;^UTILITY(U,$J,358.3,35204,1,4,0)
 ;;=4^H40.11X1
 ;;^UTILITY(U,$J,358.3,35204,2)
 ;;=^5005754
 ;;^UTILITY(U,$J,358.3,35205,0)
 ;;=H40.11X2^^163^1794^6
 ;;^UTILITY(U,$J,358.3,35205,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35205,1,3,0)
 ;;=3^Glaucoma,Primary Open-Angle,Moderate Stage
 ;;^UTILITY(U,$J,358.3,35205,1,4,0)
 ;;=4^H40.11X2
 ;;^UTILITY(U,$J,358.3,35205,2)
 ;;=^5005755
 ;;^UTILITY(U,$J,358.3,35206,0)
 ;;=H40.11X3^^163^1794^7
